|
|
|
|
|
|
|
|
Recent Questions and Answers
|
|
|
|
|
|
|
|
Recent Information On Ibs News:
|
|
|
Furiex Pharmaceuticals Inc. Posted on:07 Sep 11 Furiex Pharmaceuticals, Inc. (Nasdaq: FURX) today announced successful results from its Phase II proof-of-concept clinical trial evaluating the safety and efficacy of MuDelta, an investigational oral agent for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D).
Fill in the following fields to send this information to others. Fill in all fields with details. According to some healthcare experts, better use of an unlikely treatment could potentially save health services much needed cash.
GIA announces the release of a comprehensive global report on Irritable Bowel Syndrome (IBS) Therapeutics markets. The global market for Irritable Bowel Syndrome (IBS) Therapeutics is forecast to reach $1.47 billion by the year 2017. The market for IBS therapeutics is presently driven by the high degree of unmet therapeutic needs, high penetration of generic drugs, and under diagnosis of the ...
L-3 MAPPS announced that it has teamed with British Columbia-based Offshore Systems Limited (OSL) to provide leading solutions for Royal Canadian Navy programs. ...
Isle of Man College and International Business School
|
|
| |
|
|
|
Additional Information On Ibs Resources:
|
|
|
|
|
|
|
1.
IBS Electronics
Electronics components, computer hardware, peripherals and hard to find items.
|
2.
IBS Informationstechnik Bittenbrünn Klarmann GmbH
Das Unternehmen gibt Informationen über sein Dienstleistungsangebot im Bereich Automatisierung und Visualisierung von Industrieanlagen und Geräten unter Einsatz von SPS-Steuerungen und BedienoberflÃ
|
|
Want your site featured on this page?
|
